HNSBF - Hansa Biopharma AB GAAP EPS of -SEK3.11 revenue of SEK30.3M April, 21 2022 03:14 AM Hansa Biopharma AB Hansa Biopharma AB press release (OTC:HNSBF): Q1 GAAP EPS of -SEK3.11. Revenue of SEK30.3M (+236.7% Y/Y). For further details see: Hansa Biopharma AB GAAP EPS of -SEK3.11, revenue of SEK30.3M